BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 33312335)

  • 21. MicroRNAs in Alzheimer's disease.
    Delay C; Mandemakers W; Hébert SS
    Neurobiol Dis; 2012 May; 46(2):285-90. PubMed ID: 22285895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons.
    Absalon S; Kochanek DM; Raghavan V; Krichevsky AM
    J Neurosci; 2013 Sep; 33(37):14645-59. PubMed ID: 24027266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating miR-125b as a biomarker of Alzheimer's disease.
    Tan L; Yu JT; Liu QY; Tan MS; Zhang W; Hu N; Wang YL; Sun L; Jiang T; Tan L
    J Neurol Sci; 2014 Jan; 336(1-2):52-6. PubMed ID: 24139697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential microRNA expression analyses across two brain regions in Alzheimer's disease.
    Dobricic V; Schilling M; Schulz J; Zhu LS; Zhou CW; Fuß J; Franzenburg S; Zhu LQ; Parkkinen L; Lill CM; Bertram L
    Transl Psychiatry; 2022 Aug; 12(1):352. PubMed ID: 36038535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can Peripheral MicroRNA Expression Data Serve as Epigenomic (Upstream) Biomarkers of Alzheimer's Disease?
    Yılmaz ŞG; Erdal ME; Özge AA; Sungur MA
    OMICS; 2016 Aug; 20(8):456-61. PubMed ID: 27501295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea.
    Martínez C; Rodiño-Janeiro BK; Lobo B; Stanifer ML; Klaus B; Granzow M; González-Castro AM; Salvo-Romero E; Alonso-Cotoner C; Pigrau M; Roeth R; Rappold G; Huber W; González-Silos R; Lorenzo J; de Torres I; Azpiroz F; Boulant S; Vicario M; Niesler B; Santos J
    Gut; 2017 Sep; 66(9):1537-1538. PubMed ID: 28082316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CSF microRNA Profiling in Alzheimer's Disease: a Screening and Validation Study.
    Dangla-Valls A; Molinuevo JL; Altirriba J; Sánchez-Valle R; Alcolea D; Fortea J; Rami L; Balasa M; Muñoz-García C; Ezquerra M; Fernández-Santiago R; Lleó A; Lladó A; Antonell A
    Mol Neurobiol; 2017 Nov; 54(9):6647-6654. PubMed ID: 27738874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of microRNA-186 on oxidative stress injury of neuron by targeting interleukin 2 through the janus kinase-signal transducer and activator of transcription pathway in a rat model of Alzheimer's disease.
    Wu DM; Wen X; Wang YJ; Han XR; Wang S; Shen M; Fan SH; Zhuang J; Zhang ZF; Shan Q; Li MQ; Hu B; Sun CH; Lu J; Chen GQ; Zheng YL
    J Cell Physiol; 2018 Dec; 233(12):9488-9502. PubMed ID: 29995978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA (miRNA) Signaling in the Human CNS in Sporadic Alzheimer's Disease (AD)-Novel and Unique Pathological Features.
    Zhao Y; Pogue AI; Lukiw WJ
    Int J Mol Sci; 2015 Dec; 16(12):30105-16. PubMed ID: 26694372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNAs and MAPKs: Evidence of These Molecular Interactions in Alzheimer's Disease.
    Raffaele I; Silvestro S; Mazzon E
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Micro RNA as a potential blood-based epigenetic biomarker for Alzheimer's disease.
    Fransquet PD; Ryan J
    Clin Biochem; 2018 Aug; 58():5-14. PubMed ID: 29885309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells.
    Lukiw WJ; Zhao Y; Cui JG
    J Biol Chem; 2008 Nov; 283(46):31315-22. PubMed ID: 18801740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A MicroRNA-BDNF Negative Feedback Signaling Loop in Brain: Implications for Alzheimer's Disease.
    Keifer J; Zheng Z; Ambigapathy G
    Microrna; 2015; 4(2):101-8. PubMed ID: 26456533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Systematic Review of MicroRNA Expression as Biomarker of Late-Onset Alzheimer's Disease.
    Herrera-Espejo S; Santos-Zorrozua B; Álvarez-González P; Lopez-Lopez E; Garcia-Orad Á
    Mol Neurobiol; 2019 Dec; 56(12):8376-8391. PubMed ID: 31240600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer's disease: An integrative review.
    Millan MJ
    Prog Neurobiol; 2017 Sep; 156():1-68. PubMed ID: 28322921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-Wide Profiling of miRNA and mRNA Expression in Alzheimer's Disease.
    Chang WS; Wang YH; Zhu XT; Wu CJ
    Med Sci Monit; 2017 Jun; 23():2721-2731. PubMed ID: 28578378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The miRNome of Alzheimer's disease: consistent downregulation of the miR-132/212 cluster.
    Pichler S; Gu W; Hartl D; Gasparoni G; Leidinger P; Keller A; Meese E; Mayhaus M; Hampel H; Riemenschneider M
    Neurobiol Aging; 2017 Feb; 50():167.e1-167.e10. PubMed ID: 27816213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease.
    Denk J; Boelmans K; Siegismund C; Lassner D; Arlt S; Jahn H
    PLoS One; 2015; 10(5):e0126423. PubMed ID: 25992776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-Expression Network Analysis of Micro-RNAs and Proteins in the Alzheimer's Brain: A Systematic Review of Studies in the Last 10 Years.
    Tasker R; Rowlands J; Ahmed Z; Di Pietro V
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNAs Modulate the Pathogenesis of Alzheimer's Disease: An In Silico Analysis in the Human Brain.
    Gugliandolo A; Chiricosta L; Boccardi V; Mecocci P; Bramanti P; Mazzon E
    Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32846925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.